Geftinat 250mg|Gefticip 250mg is considered as first line therapy in non-small cell lung carcinoma in metastatic stage, tumor cell containing epidermal growth factor receptors like exon 19 deletion or exon 21 substitution mutations which is identified by FDA approved test. #Geftinat250mg #Gefticip250mg #Gefitinib250mg #Iressa